- Advertisement -
AUSTIN, Texas–(BUSINESS WIRE)–Faeth Therapeutics, Inc. (Nasdaq: FTH) today announced that the Compensation Committee of Faeth’s Board of Directors granted three new employees options to purchase an aggregate of 94,000 shares of the Company’s common stock in connection with their employment…
Click here to view the original article.
